SCIE期刊BREAST CANCER RESEARCH AND TREATMENT 2024/2025影响因子:3.186 (BREAST CANCER RES TR) (0167-6806). (ONCOLOGY)(肿瘤学)Scien

显示全部楼层 · 发表于 2025-3-23 21:03:40

Submitted on: 27 September 2023. Revised on: 09 January 2024. Accepted on: 15 February 2024. ___________________BREAST CANCER RESEARCH AND TREATMENT

显示全部楼层 · 发表于 2025-3-23 23:23:53

显示全部楼层 · 发表于 2025-3-24 03:01:27

Submitted on: 21 June 2018. Revised on: 13 September 2018. Accepted on: 16 October 2018. ___________________BREAST CANCER RESEARCH AND TREATMENT

显示全部楼层 · 发表于 2025-3-24 07:56:10

显示全部楼层 · 发表于 2025-3-24 13:33:20

显示全部楼层 · 发表于 2025-3-24 15:13:36

Submitted on: 13 July 2006. Revised on: 03 November 2006. Accepted on: 17 December 2006. ___________________BREAST CANCER RESEARCH AND TREATMENT

显示全部楼层 · 发表于 2025-3-24 22:39:54

显示全部楼层 · 发表于 2025-3-25 03:11:13

Submitted on: 19 April 2022. Revised on: 06 June 2022. Accepted on: 20 July 2022. ___________________BREAST CANCER RESEARCH AND TREATMENT

用户名		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 11:54
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved